Robert Kramer, former CEO of Emergent BioSolutions, allegedly earned more than $10.1 million by executing trades with ...
Robert Kramer was the CEO of Emergent BioSolutions, a government contractor.
By Jonathan Stempel NEW YORK, Jan 15 (Reuters) - A former chief executive of Emergent BioSolutions was charged on Thursday ...
Letitia James accused Robert Kramer of selling his shares in Emergent before disclosing contamination issues in its ...
Former Emergent BioSolutions Inc. CEO Robert Kramer engaged in illegal insider trading during the Covid-19 pandemic, ...
New York's attorney general has filed an insider trading lawsuit against former Emergent BioSolutions CEO Robert Kramer, ...
A former biotech CEO pocketed more than $10 million by selling company stock after learning of serious COVID-19 vaccine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results